Publicaciones en colaboración con investigadores/as de Universidad Europea de Madrid (35)

2019

  1. Association of HTR2A-1438G/A Genetic Polymorphism With Smoking and Chronic Obstructive Pulmonary Disease

    Archivos de Bronconeumologia, Vol. 55, Núm. 3, pp. 128-133

2017

  1. A Paradox: α-Klotho Levels and Smoking Intensity

    Lung, Vol. 195, Núm. 1, pp. 53-57

2016

  1. Effect of genetic polymorphisms and long-term tobacco exposure on the risk of breast cancer

    International Journal of Molecular Sciences, Vol. 17, Núm. 10

  2. Factores de riesgo cardiovascular en una población de trabajadores del mar de España

    Archivos de prevención de riesgos laborales, Vol. 19, Núm. 4, pp. 215-221

  3. Hábito tabáquico en trabajadores del mar

    Revista de la Asociacion Espanola de Especialistas en Medicina del Trabajo, Vol. 25, Núm. 3, pp. 166-175

  4. Perceived environment in relation to objective and self-reported physical activity in Spanish youth. The UP&DOWN study

    Journal of Sports Sciences, Vol. 34, Núm. 15, pp. 1423-1429

  5. The effect of polymorphisms in DNA repair genes and carcinogen metabolizers on leukocyte telomere length: A cohort of healthy Spanish smokers

    Nicotine and Tobacco Research, Vol. 18, Núm. 4, pp. 447-452

2015

  1. Are SNP-Smoking association studies needed in controls? DNA repair gene polymorphisms and smoking intensity

    PLoS ONE, Vol. 10, Núm. 5

  2. Effects of cigarette smoking and nicotine metabolite ratio on leukocyte telomere length.

    Environmental Research, Vol. 140, pp. 488-494

  3. Impacts of the glucuronidase genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on tamoxifen metabolism in breast cancer patients

    PLoS ONE, Vol. 10, Núm. 7

  4. Lipoatrofia semicircular de etiología laboral asociada a alteraciones séricas de adipocinas

    Medicina Clinica, Vol. 145, Núm. 8, pp. 338-340

2014

  1. Adjusting the dose of tamoxifen in patients with early breast cancer and CYP2D6 poor metabolizer phenotype

    Breast, Vol. 23, Núm. 4, pp. 400-406

  2. Are serotonergic system genes associated to smoking cessation therapy success in addition to CYP2A6 ?

    Pharmacopsychiatry, Vol. 47, Núm. 1, pp. 33-36

  3. Follow-up in healthy schoolchildren and in adolescents with DOWN syndrome: Psycho-environmental and genetic determinants of physical activity and its impact on fitness, cardiovascular diseases, inflammatory biomarkers and mental health; The UP&DOWN Study

    BMC Public Health, Vol. 14, Núm. 1

2013

  1. Case-control study of semicircular lipoatrophy, a new occupational disease in office workers

    Journal of Occupational Health, Vol. 55, Núm. 3, pp. 149-157

  2. Relationship between Genotypes Sult1a2 and Cyp2d6 and Tamoxifen Metabolism in Breast Cancer Patients

    PLoS ONE, Vol. 8, Núm. 7

  3. Tamoxifen therapy in breast cancer: Do apolipoprotein E genotype and menopausal state affect plasma lipid changes induced by the drug?

    International Journal of Biological Markers, Vol. 28, Núm. 4

2012

  1. CYP2D6*4 allele and breast cancer risk: Is there any association?

    Clinical and Translational Oncology, Vol. 14, Núm. 2, pp. 157-159

2011

  1. 'Smoking Genes': A genetic association study

    PLoS ONE, Vol. 6, Núm. 10

2010

  1. A novel, single algorithm approach to predict acenocoumarol dose based on CYP2C9 and VKORC1 allele variants

    PLoS ONE, Vol. 5, Núm. 6